The invention relates to a stable oral liquid formulation developed for treating negative effects of Advanced Glycation end Products (AGEs) in a clear oral liquid formulation containing Resveratrol, Benfotiamine, Pyridoxamine and one or more pharmaceutically active agents in a suitable vehicle and an effective amoun...
The invention discloses a dermaceutical cream containing steroids and an
antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in
situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate
is converted into Fusidic acid under oxygen-free environment. The cream of th...
The invention discloses a dermaceutical cream containing antifungal agents,
steroids and an antibacterial agent in the form of Fusidic acid, which Fusidic acid
is formed in situ from Sodium Fusidate as the starting raw material, wherein
Sodium Fusidate is converted into Fusidic acid under oxygen-free environme...
The invention discloses a process to make dermaccutical gel containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment comprising an inert gas, preferably nitrogen. The gel produced by the pro...
The invention discloses a dermaceutical cream containing Betamethasone Valerate as
a corticosteroid, and an antibacterial agent in the form of Fusidic acid, which Fusidic
acid is formed in situ from Sodium Fusidate as the starting raw material, wherein
Sodium Fusidate is converted into Fusidic -acid under oxyg...
The invention discloses a dermaceutical cream containing Mometasone Furoate as a corticosteroid, an antifungal agent in the form of Clotrimazole and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is c...
The invention discloses a dermaceutical cream containing Mometasone Furoate as a steroid, Miconazole Nitrate as an antifungal, and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusi...
The invention discloses a dermaceutical cream containing Clobetasol Propionate as a steroid, Clotrimazole as an antifungal and an antibacterial agent in the form of
Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the
starting raw material, wherein Sodium Fusidate is converted into Fusi...
The invention discloses a dermaceutical cream containing Fluticasone Propionate as a corticosteroid, and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free...
The invention discloses a dermaceutical cream containing Fluticasone Propionate as a steroid, Miconazole Nitrate as an antifungal agent and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted ...
The invention discloses a dermaceutical cream containing Mometasone furoate as a corticosteroid, and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free env...
The invention discloses a dermaceutical cream containing Fluticasone Propionate as a corticosteroid, an antifungal agent in the form of Clotrimazole and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, Nvherein Sodium Fusidate...
A Dermaceutical Gel Made Using Sodium Fusidate And A Process To Make It
The invention discloses a process to make dermaceutical gel containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment ...
The present invention relates to primary and secondary bacterial skin infections and in
particular it relates to the treatment of these infections using a Fusidic acid cream that has
been made using Sodium fusidate as the starting Active Pharmaceutical Ingredient (API).
The invention discloses a dermaceutical ...
The invention discloses a process to make dermaceutical cream containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment created using inert gas, preferably nitrogen. The cream produced by the...
[Class : 5] Medicinal, Pharmaceutical And Veterinary Preparations; Dietetic Beverages Adapted For Medical Purposes, Sanitary Preparations For Medical Purposes; Medicinal Herbs; Dietetic Substances Adapted For Medical Use, Food For Babies; Nutritional Supplements, Protein Dietary Supplements, Mineral Food Supplements, Vitamin Preparations; Dietary Supplements
[Class : 5] Medicinal, Pharmaceutical And Veterinary Preparations; Dietetic Beverages Adapted For Medical Purposes, Sanitary Preparations For Medical Purposes; Medicinal Herbs; Dietetic Substances Adapted For Medical Use, Food For Babies; Nutritional Supplements, Protein Dietary Supplements, Mineral Food Supplements, Vitamin Preparations; Dietary Supplements